Avadel Pharmaceuticals PLC
AVDL
Mkt cap
$968.53M
EV/Sales
5.42
P/E ratio
N/A
FY2024 Revenue
$169.12M
EPS (TTM)
$0.00
Gross Margin (FY2024)
90.97%
Profit Margin (FY2024)
-28.87%
Beta
1.63
Div yield
N/A
Sector
Healthcare
Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.
Use this AVDL research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full AVDL income, balance, and cash tables.
Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Avadel Pharmaceuticals PLC (AVDL) revenue for Dec 31, 2024 was $169.1M. Net income was -$48.8M. Statements: https://lician.com/financials/avdl
Avadel Pharmaceuticals PLC (AVDL) market capitalization is $968.5M on the latest cached snapshot.
The latest cached AVDL filing is 8-K · Jan 12, 2026. Filings: https://lician.com/sec/avdl